✦ LIBER ✦

Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases

✍ Scribed by Coleman, R.E.; Dirix, L.Y.; Dodwell, D.; Tubiana-Hulin, M.; Body, J.-J.; Becher, R.; White, G.K.; Rubens, R.D.; Van Oosterom, A.; Howell, A.

Book ID: 122919950
Publisher: Elsevier Science
Year: 1991
Weight: 319 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90158-A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

30. A randomized phase 11 evaluation of

30. A randomized phase 11 evaluation of oral pamidronate for advanced bone metastases from breast cancer

✍ R.E. Coleman; R.D. Rubens; C. Rose; O.P. Purohit; S. Houston; J. Ford 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 307 KB

A randomised phase II study of oral pami

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer

✍ R.E Coleman; S Houston; O.P Purohit; R.D Rubens; A Kandra; J Ford 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Efficacy and safety of medical ozone (O3

Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I–II study

✍ Carla Ida Ripamonti; Enrico Cislaghi; Luigi Mariani; Massimo Maniezzo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 322 KB

7008 POSTER DISCUSSION Twenty-four-month

7008 POSTER DISCUSSION Twenty-four-month Safety Data From Phase II Studies of Radium-223 Chloride, a First-in-class Alpha-pharmaceutical With a Highly Favorable Safety Profile for Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases

✍ Nilsson, S.; Haugen, I.; Aksnes, A.; O'Bryan-Tear, C.G.; Parker, C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB